The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes.

Diabetes Res Clin Pract 2004 Jul;65(1):21-8

Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Objective: The purpose of the present study was to assess the impact of Mg + Zn, Vitamins C + E, and combination of these micronutrients on serum lipid and lipoprotein profiles in type 2 diabetic patients.

Materials And Methods: In a randomized, double-blind, placebo controlled clinical trial, 69 type 2 diabetic patients were randomly divided into four groups, each group receiving one of the following daily supplement for 3 months; group M: 200 mg Mg and 30 mg Zn (n = 16), group V: 200mg Vitamin C and 150 mg Vitamin E (n = 18), group MV: minerals plus vitamins (n = 17), group P: placebo (n = 18). Fasting blood and urine samples were collected at the beginning and at the end of the trial. Serum triglyceride, total cholesterol, high density lipoprotein cholesterol (HDL-c) and low density lipoprotein cholesterol (LDL-c) were measured enzymatically. Apolipoproteins (apo) A1 and B were measured by immunoturbidimetric method. Adjustment for differences in baselines covariates and changes in variables during study were performed by analysis of covariance using general linear models.

Results: Results indicate that after 3 months of supplementation mean serum levels of HDL-c and apo A1 increased significantly in the MV group by 24% (50.4 +/-19.3 mg/dl versus 40.6 +/- 10.8 mg/dl) and 8.8% (169.8 +/- 33.8 mg/dl versus 156.1+ /- 23.9 mg/dl), respectively (P < 0.01). There were no significant changes in the levels of these parameters in the other three groups. Serum levels of total cholesterol, LDL-c, triglyceride, and apo B were not altered after supplementation in all four groups.

Conclusion: It is concluded that since co-supplementation of Mg, Zn, Vitamins C and E significantly increases HDL-c and apo A1, supplementation of these micronutrients could be recommended for the type 2 diabetic patients based on their daily requirements.

Download full-text PDF

Source Listing
July 2004

Publication Analysis

Top Keywords

type diabetic
diabetic patients
mg/dl versus
density lipoprotein
lipoprotein cholesterol
cholesterol ldl-c
total cholesterol
profiles type
serum levels
hdl-c apo
changes variables
study performed
variables study
covariates changes
differences baselines
baselines covariates
performed analysis
analysis covariance
adjustment differences

Similar Publications

The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.

J Ren Nutr 2002 Jul;12(3):183-9

Food and Nutrition Services, Charlton Methodist Hospital, Dallas, TX, USA.

Objective: To examine the effect of zinc sulfate supplementation on the concentrations of serum zinc and serum cholesterol in hemodialysis (HD) patients.

Setting: Outpatient dialysis center in a large metropolitan city.

Design: Randomized, double-blind, before-after trial. Read More

View Article and Full-Text PDF
July 2002

The salutary effects of antioxidant vitamins on the plasma lipids of healthy middle aged-to-elderly individuals: a randomized, double-blind, placebo-controlled study.

J Med Liban 2002 Jan-Apr;50(1-2):10-3

Department of Cardiology, Shiraz University of Medical Sciences, Shiraz, Iran.

Study Objective: To determine the efficacy of antioxidant vitamins C and E in lowering the serum lipid levels in apparently healthy middle aged-to-elderly subjects.

Design: Randomized, double-blind, placebo-controlled trial.

Setting: University outpatient clinic. Read More

View Article and Full-Text PDF
October 2003

[The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels].

Anadolu Kardiyol Derg 2004 Dec;4(4):318-22

Department of Cardiology, Medical Faculty, Başkent University, Ankara.

Objective: This study was designed to compare the effects of simvastatin versus a combination of simvastatin with vitamin C or E on serum lipid profile, particularly, high-density lipoprotein (HDL)-cholesterol (C) level, in patients with a low HDL-C level.

Methods: Fifty-nine women and 49 men, who had a baseline HDL-C level equal to or lower than 40 mg/dl were randomized to one of the following study treatment groups: Group S (n=39) simvastatin 20 mg/day, Group S+C (n=33) simvastatin 20 mg/day + vitamin C 500 mg/day, and Group S+E (n=36) simvastatin 20 mg/day + vitamin E 400 IU/day. The groups' lipid profiles were obtained at baseline, 3rd and 6th months. Read More

View Article and Full-Text PDF
December 2004

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Clin Ther 2006 May;28(5):679-88

Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

Background: Although the metabolic effects of the thiazolidinediones have been well studied, there is a lack of comparative data on their effects on certain cardiovascular risk factors, such as elevated plasma levels of lipoprotein (a) (Lp[a]) and homocysteine (Hcy).

Objective: This study compared the effects of pioglitazone or rosiglitazone added to glimepiride on a range of lipid parameters, focusing on Lp(a) and Hcy, in patients with type 2 diabetes mellitus and the metabolic syndrome.

Methods: This was a multicenter, randomized, controlled, double-blind study in patients with type 2 diabetes and the metabolic syndrome (hypertension [>or=130/85 mm Hg]) and triglyceridemia (>or=150 mg/dL). Read More

View Article and Full-Text PDF
May 2006